An overlap syndrome of myasthenia gravis, myocarditis, myositis and hepatitis triggered by immune checkpoint inhibitor use Cover

.blurhash-client-img { display: none !important; }

An overlap syndrome of myasthenia gravis, myocarditis, myositis and hepatitis triggered by immune checkpoint inhibitor use

Forum of Clinical Oncology

By: Philip Macilwraith, Darren Ngo, Hossein Zareie, Zi-Hao Tan and Chun Loo Gan

Open Access

|May 2025

Metrics

DOI: https://doi.org/10.2478/fco-2024-0004 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Submitted on: Aug 1, 2024

Accepted on: Nov 24, 2024

Published on: May 18, 2025

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Myasthenia gravis,

immune checkpoint inhibitors,

immune-related adverse effects,

metastatic melanoma

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2025 Philip Macilwraith, Darren Ngo, Hossein Zareie, Zi-Hao Tan, Chun Loo Gan, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.